Last reviewed · How we verify
Thioridazine-2-Sulfoxide (MESORIDAZINE)
At a glance
| Generic name | MESORIDAZINE |
|---|---|
| Drug class | Phenothiazine |
| Target | Histamine H1 receptor |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
| First approval | 1970 |
Approved indications
- Schizophrenia
Common side effects
Drug interactions
- moxifloxacin
- paroxetine
- pindolol
- propranolol
- quetiapine
- quinine
- ziprasidone
Key clinical trials
- Reducing Antipsychotic-Induced Weight Gain in Children With Metformin (PHASE1)
- Antipsychotics and Risk of Hyperglycemic Emergencies
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |